首页> 中文期刊> 《心血管病学进展》 >胰高血糖素样肽1对心血管系统作用的研究进展

胰高血糖素样肽1对心血管系统作用的研究进展

         

摘要

胰高血糖素样肽1是体内一种重要的肠促胰素,能够通过多种途径降低血糖,在调节葡萄糖稳态中起重要作用,可用于预防和治疗糖尿病.胰高血糖素样肽1的受体分布广泛,除了胰腺组织外,还分布于脑、肺脏、心脏、肾脏等.近年来对胰高血糖素样肽1的研究发现其对心血管系统具有保护作用,如调节心率、血压,改善血管内皮功能、舒张血管、改善心肌缺血、改善心功能等.对这些作用的研究将为临床治疗糖尿病和心血管疾病提供新的方法.%Glucagon-like peptide-1 (GLP-I) is an incretin that lowers blood glucose through several mechanisms, and plays an impor-tant role in the regulation of glucose homeostasis. GLP-1 's function in glucose homeostasis may make it useful in the prevention and treatment of diabetes. GLP-1 may also be important in treating cardiac issues. The GLP-1 receptor is widely distributed in the body. It is found in the brain, lung, heart, kidney and the pancreas. Recent studies have shown that GLP-1 has a protective effect on the cardiovascular system. It has been found to regulate heart rate and blood pressure, relax vascular vessels, improve endothelial function, and protect ischemic myocar- , dium. Abnormalities of cardiovascular systems are common in diabetic patients. Further research into the effects of GLP-1 throughout the hu-man body may shed light on how it can be used in the treatment of diabetes and heart disease.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号